New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ -- Quest Diagnostics (DGX), a ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

Teaching of flow cytometry, histocompatibility, and immunology are combined into a one month rotation with the resident spending two weeks in flow cytometry, one week in the histocompatibility ...

While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...

Antimicrobial resistance is a growing threat to the health and safety of the world’s population. The World Health Organisation recognizes faster, more accurate laboratory detection of antimicrobial ...

DUBLIN--(BUSINESS WIRE)--The "2020 Global Hematology and Flow Cytometry Lab and POC Market: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest ...

Back in December 2019, a cluster of patients in Wuhan, China, developed pneumonia of an unknown etiology. Since then, the full genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ --Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced ...

"Our Flow Cytometry MRD for Myeloma test harnesses cutting-edge science and technology to deliver ultrasensitive insights from a noninvasive blood test, thereby improving care and value for patients ...